Inspire Medical Systems, Inc.
INSP
$81.79
-$2.02-2.41%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.42% | 7.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.42% | 7.83% | |||
| Cost of Revenue | -8.36% | 12.91% | |||
| Gross Profit | 5.65% | 6.92% | |||
| SG&A Expenses | -0.41% | 10.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.52% | 8.68% | |||
| Operating Income | 390.83% | -123.30% | |||
| Income Before Tax | 681.09% | -156.07% | |||
| Income Tax Expenses | 187.22% | 7.97% | |||
| Earnings from Continuing Operations | 376.50% | -220.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 376.50% | -220.05% | |||
| EBIT | 390.83% | -123.30% | |||
| EBITDA | 13,492.86% | -93.71% | |||
| EPS Basic | 378.23% | -220.85% | |||
| Normalized Basic EPS | 932.78% | -58.51% | |||
| EPS Diluted | 378.23% | -221.70% | |||
| Normalized Diluted EPS | 923.69% | -57.69% | |||
| Average Basic Shares Outstanding | -0.59% | -0.66% | |||
| Average Diluted Shares Outstanding | 0.32% | -2.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||